Pharmacokinetics of Ritonavir and Delavirdine in Human Immunodeficiency Virus-Infected Patients

To evaluate the pharmacokinetic effect of adding delavirdine mesylate to the antiretroviral regimens of human immunodeficiency virus (HIV)-infected patients stabilized on a full dosage of ritonavir (600 mg every 12 h), 12 HIV-1-infected subjects had delavirdine mesylate (400 mg every 8 h) added to t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Shelton, Mark J., Hewitt, Ross G., Adams, John, Della-Coletta, Andrew, Cox, Steven, Morse, Gene D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2003
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC153300/
https://ncbi.nlm.nih.gov/pubmed/12709342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.5.1694-1699.2003
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak